Monday, June 12, 2017
Open Access Article : "HR+, HER2– Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of action, Clinical Activity, and Safety Profiles"
Related Posts:
Free Trial Request
Most Citied Article : Role of Inflammation-Associated Microenvironment in Tumorigenesis and Metastasis
New Issue Published Current Cancer Drug Targets Vol 17 issue 9
New Issue Published Current Cancer Drug Targets Vol 17 issue 8
Most Accessed Article : Influence of Aldo-keto Reductase 1C3 in Prostate Cancer - A Mini Review
0 comments:
Post a Comment